Literature DB >> 7028075

Variations in the opsonic requirements of group B streptococcus type III.

M J Hastings, C S Easmon.   

Abstract

The opsonic requirements of strains of Type III Group B streptococci (GBS) were studied using Luminol-dependent chemiluminescence and microscopy. Growth and storage conditions, particularly any reduction in the pH of the medium, affected GBS resistance to opsonization. Opsonization was complement-dependent but there was considerable variation in the requirements of individual strains for the classical and alternative pathways. Antibody was also necessary for opsonization. A few type III GBS strains were resistant to opsonization by pooled serum known to contain type-specific antibody, raising the possibility that protective antibody might in certain circumstances be strain- rather than type-specific. Treatment of these strains with neuraminidase, however, rendered them sensitive to opsonization by the same pool of serum. The resistance of GBS to opsonization in the neonate, where complement activity can be reduced and antibody levels are low, may be a major determinant of virulence.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028075      PMCID: PMC2041706     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  9 in total

Review 1.  Perinatal and neonatal infections: infections with group-B streptococci.

Authors:  M T Parker
Journal:  J Antimicrob Chemother       Date:  1979-05       Impact factor: 5.790

2.  Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.

Authors:  T W Milligan; C J Baker; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

3.  Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b.

Authors:  M D Kazatchkine; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

4.  Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.

Authors:  R S Baltimore; D L Kasper; C J Baker; D K Goroff
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

5.  Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.

Authors:  A J Williams; M J Hastings; C S Easmon; P J Cole
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

6.  Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera.

Authors:  D C Anderson; M S Edwards; C J Baker
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

7.  Mouse protection test for group B Streptococcus type III.

Authors:  R S Baltimore; D L Kasper; J Vecchitto
Journal:  J Infect Dis       Date:  1979-07       Impact factor: 5.226

8.  Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.

Authors:  V G Hemming; R T Hall; P G Rhodes; A O Shigeoka; H R Hill
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

9.  The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.

Authors:  M S Edwards; A Nicholson-Weller; C J Baker; D L Kasper
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

  9 in total
  8 in total

1.  Clinical versus laboratory strains of Group B streptococci and human neutrophil chemiluminescence.

Authors:  M J Kowolik; C G Cumming
Journal:  J Clin Pathol       Date:  1984-02       Impact factor: 3.411

2.  Fatal late-onset group B streptococcal sepsis on a special care baby unit.

Authors:  M J Hastings; R P Rivers; C S Easmon
Journal:  Postgrad Med J       Date:  1982-10       Impact factor: 2.401

3.  What is the risk of beta-haemolytic streptococcal infection in obstetrics?: discussion paper.

Authors:  C S Easmon
Journal:  J R Soc Med       Date:  1984-04       Impact factor: 5.344

4.  Opsonization of group B Streptococcus type III: studies using clinical strains and maternal sera.

Authors:  M J Hastings; J Neil; C S Easmon
Journal:  Br J Exp Pathol       Date:  1985-06

5.  Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.

Authors:  N R Payne; Y K Kim; P Ferrieri
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

6.  Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide.

Authors:  P Rainard; C Boulard
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

7.  Sialic acid levels and lag time of growth in chemically defined medium containing 200 mM phosphate among strains of various serotypes of Streptococcus agalactiae.

Authors:  Y Nagano; N Nagano; S Takahashi; A Suzuki; Y Okuwaki
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

8.  Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.